Flag Ship Acquisition (ETHZ) Competitors

$4.13 -0.41 (-9.03%)

As of 05/26/2026

ETHZ vs. SRZN, AMRN, RGNX, NAGE, and ABEO

Should you buy Flag Ship Acquisition stock or one of its competitors? MarketBeat compares Flag Ship Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Flag Ship Acquisition include Surrozen (SRZN), Amarin (AMRN), REGENXBIO (RGNX), Niagen Bioscience (NAGE), and Abeona Therapeutics (ABEO). These companies are all part of the "pharmaceutical products" industry.

How does Flag Ship Acquisition compare to Surrozen?

Flag Ship Acquisition (NASDAQ:ETHZ) and Surrozen (NASDAQ:SRZN) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Flag Ship Acquisition has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market. Comparatively, Surrozen has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

In the previous week, Surrozen had 1 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 1 mentions for Surrozen and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score.

Company	Overall Sentiment
Flag Ship Acquisition	Neutral
Surrozen	Neutral

Flag Ship Acquisition has higher revenue and earnings than Surrozen. Surrozen is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flag Ship Acquisition	$4.11M	19.10	-$6.17M	-$159.65	N/A
Surrozen	$3.48M	88.36	-$242.03M	-$37.59	N/A

Surrozen has a consensus price target of $42.00, suggesting a potential upside of 58.57%. Given Surrozen's stronger consensus rating and higher possible upside, analysts clearly believe Surrozen is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Surrozen	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80

Flag Ship Acquisition has a net margin of 0.00% compared to Surrozen's net margin of -4,810.50%. Flag Ship Acquisition's return on equity of -185.71% beat Surrozen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-185.71%	-83.12%
Surrozen	-4,810.50%	-4,055.04%	-154.08%

4.1% of Flag Ship Acquisition shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 15.1% of Flag Ship Acquisition shares are held by company insiders. Comparatively, 31.7% of Surrozen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Surrozen beats Flag Ship Acquisition on 9 of the 16 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Amarin?

Flag Ship Acquisition (NASDAQ:ETHZ) and Amarin (NASDAQ:AMRN) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

In the previous week, Amarin had 3 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 3 mentions for Amarin and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 beat Amarin's score of -0.05 indicating that Flag Ship Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Flag Ship Acquisition	Neutral
Amarin	Neutral

Amarin has a consensus price target of $12.00, indicating a potential downside of 16.93%. Given Amarin's stronger consensus rating and higher probable upside, analysts plainly believe Amarin is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Amarin	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

Flag Ship Acquisition has higher earnings, but lower revenue than Amarin. Amarin is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flag Ship Acquisition	$4.11M	19.10	-$6.17M	-$159.65	N/A
Amarin	$216.76M	1.40	-$38.80M	-$0.65	N/A

4.1% of Flag Ship Acquisition shares are held by institutional investors. Comparatively, 22.3% of Amarin shares are held by institutional investors. 15.1% of Flag Ship Acquisition shares are held by company insiders. Comparatively, 4.2% of Amarin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Flag Ship Acquisition has a net margin of 0.00% compared to Amarin's net margin of -15.51%. Amarin's return on equity of -2.99% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-185.71%	-83.12%
Amarin	-15.51%	-2.99%	-2.07%

Flag Ship Acquisition has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market. Comparatively, Amarin has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

Summary

Amarin beats Flag Ship Acquisition on 8 of the 15 factors compared between the two stocks.

How does Flag Ship Acquisition compare to REGENXBIO?

Flag Ship Acquisition (NASDAQ:ETHZ) and REGENXBIO (NASDAQ:RGNX) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

REGENXBIO has a consensus price target of $23.91, suggesting a potential upside of 266.14%. Given REGENXBIO's stronger consensus rating and higher probable upside, analysts plainly believe REGENXBIO is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
REGENXBIO	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Flag Ship Acquisition has a net margin of 0.00% compared to REGENXBIO's net margin of -330.23%. Flag Ship Acquisition's return on equity of -185.71% beat REGENXBIO's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-185.71%	-83.12%
REGENXBIO	-330.23%	-232.50%	-61.02%

Flag Ship Acquisition has higher earnings, but lower revenue than REGENXBIO. REGENXBIO is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flag Ship Acquisition	$4.11M	19.10	-$6.17M	-$159.65	N/A
REGENXBIO	$87.82M	3.84	-$193.88M	-$5.60	N/A

Flag Ship Acquisition has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, REGENXBIO has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

In the previous week, REGENXBIO had 2 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 2 mentions for REGENXBIO and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 equaled REGENXBIO'saverage media sentiment score.

Company	Overall Sentiment
Flag Ship Acquisition	Neutral
REGENXBIO	Neutral

4.1% of Flag Ship Acquisition shares are held by institutional investors. Comparatively, 88.1% of REGENXBIO shares are held by institutional investors. 15.1% of Flag Ship Acquisition shares are held by insiders. Comparatively, 14.2% of REGENXBIO shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

REGENXBIO beats Flag Ship Acquisition on 8 of the 15 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Niagen Bioscience?

Flag Ship Acquisition (NASDAQ:ETHZ) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

Niagen Bioscience has higher revenue and earnings than Flag Ship Acquisition. Flag Ship Acquisition is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flag Ship Acquisition	$4.11M	19.10	-$6.17M	-$159.65	N/A
Niagen Bioscience	$129.42M	2.43	$17.38M	$0.21	18.80

Niagen Bioscience has a net margin of 14.29% compared to Flag Ship Acquisition's net margin of 0.00%. Niagen Bioscience's return on equity of 22.68% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flag Ship Acquisition	N/A	-185.71%	-83.12%
Niagen Bioscience	14.29%	22.68%	16.23%

4.1% of Flag Ship Acquisition shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by company insiders. Comparatively, 10.0% of Niagen Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Flag Ship Acquisition has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.17, suggesting that its share price is 117% more volatile than the broader market.

In the previous week, Niagen Bioscience had 1 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 1 mentions for Niagen Bioscience and 0 mentions for Flag Ship Acquisition. Niagen Bioscience's average media sentiment score of 1.00 beat Flag Ship Acquisition's score of 0.00 indicating that Niagen Bioscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Flag Ship Acquisition	Neutral
Niagen Bioscience	Positive

Niagen Bioscience has a consensus target price of $14.67, suggesting a potential upside of 271.40%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Niagen Bioscience is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Niagen Bioscience beats Flag Ship Acquisition on 14 of the 16 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Abeona Therapeutics?

Abeona Therapeutics (NASDAQ:ABEO) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

Abeona Therapeutics has higher revenue and earnings than Flag Ship Acquisition. Flag Ship Acquisition is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abeona Therapeutics	$14.54M	22.28	$71.18M	$0.97	5.86
Flag Ship Acquisition	$4.11M	19.10	-$6.17M	-$159.65	N/A

Abeona Therapeutics has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

80.6% of Abeona Therapeutics shares are owned by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are owned by institutional investors. 5.4% of Abeona Therapeutics shares are owned by company insiders. Comparatively, 15.1% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Abeona Therapeutics' return on equity of -53.98% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abeona Therapeutics	N/A	-53.98%	-38.52%
Flag Ship Acquisition	N/A	-185.71%	-83.12%

Abeona Therapeutics presently has a consensus price target of $19.00, indicating a potential upside of 234.21%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Abeona Therapeutics is more favorable than Flag Ship Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abeona Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Abeona Therapeutics had 11 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 11 mentions for Abeona Therapeutics and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 beat Abeona Therapeutics' score of -0.37 indicating that Flag Ship Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Abeona Therapeutics	Neutral
Flag Ship Acquisition	Neutral

Summary

Abeona Therapeutics beats Flag Ship Acquisition on 13 of the 15 factors compared between the two stocks.

Get Flag Ship Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ETHZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ETHZ vs. The Competition

Export

Metric	Flag Ship Acquisition	Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$78.52M	$2.98B	$4.28B	$12.46B
Dividend Yield	N/A	15.23%	5.93%	5.27%
P/E Ratio	-0.03	13.11	21.97	25.92
Price / Sales	19.10	1,754.80	242.53	69.57
Price / Cash	N/A	27.64	55.68	56.67
Price / Book	0.14	5.98	32.32	7.16
Net Income	-$6.17M	-$42.06M	$112.32M	$336.99M
7 Day Performance	5.63%	1.12%	3.57%	3.36%
1 Month Performance	-15.20%	2.06%	4.81%	3.50%
1 Year Performance	N/A	18.75%	15.60%	36.16%

Flag Ship Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ETHZ Flag Ship Acquisition	N/A	$4.13 -9.0%	N/A	N/A	$78.52M	$4.11M	N/A	7	News Coverage
SRZN Surrozen	3.0232 of 5 stars	$27.05 +5.8%	$42.00 +55.3%	+228.8%	$296.88M	$3.48M	N/A	80
AMRN Amarin	0.7455 of 5 stars	$14.27 +1.6%	$12.00 -15.9%	+28.7%	$294.61M	$216.76M	N/A	360
RGNX REGENXBIO	2.6578 of 5 stars	$5.97 +5.5%	$23.91 +300.5%	-35.0%	$292.61M	$170.44M	N/A	370
NAGE Niagen Bioscience	4.0893 of 5 stars	$3.75 +2.2%	$14.67 +291.1%	-60.9%	$292.30M	$129.42M	17.86	120	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ETHZ) was last updated on 5/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Flag Ship Acquisition (ETHZ) Competitors

ETHZ vs. SRZN, AMRN, RGNX, NAGE, and ABEO

How does Flag Ship Acquisition compare to Surrozen?

Summary

How does Flag Ship Acquisition compare to Amarin?

Summary

How does Flag Ship Acquisition compare to REGENXBIO?

Summary

How does Flag Ship Acquisition compare to Niagen Bioscience?

Summary

How does Flag Ship Acquisition compare to Abeona Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ETHZ vs. The Competition

Flag Ship Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Flag Ship Acquisition (ETHZ) Competitors

ETHZ vs. SRZN, AMRN, RGNX, NAGE, and ABEO

How does Flag Ship Acquisition compare to Surrozen?

Which has more risk & volatility, ETHZ or SRZN?

Does the media favor ETHZ or SRZN?

Which has preferable valuation and earnings, ETHZ or SRZN?

Do analysts prefer ETHZ or SRZN?

Is ETHZ or SRZN more profitable?

Do insiders and institutionals believe in ETHZ or SRZN?

Summary

How does Flag Ship Acquisition compare to Amarin?

Does the media favor ETHZ or AMRN?

Do analysts prefer ETHZ or AMRN?

Which has higher valuation & earnings, ETHZ or AMRN?

Do institutionals and insiders believe in ETHZ or AMRN?

Is ETHZ or AMRN more profitable?

Which has more risk and volatility, ETHZ or AMRN?

Summary

How does Flag Ship Acquisition compare to REGENXBIO?

Do analysts recommend ETHZ or RGNX?

Is ETHZ or RGNX more profitable?

Which has higher earnings & valuation, ETHZ or RGNX?

Which has more risk and volatility, ETHZ or RGNX?

Does the media favor ETHZ or RGNX?

Do institutionals & insiders hold more shares of ETHZ or RGNX?

Summary

How does Flag Ship Acquisition compare to Niagen Bioscience?

Which has higher valuation and earnings, ETHZ or NAGE?

Is ETHZ or NAGE more profitable?

Do institutionals and insiders hold more shares of ETHZ or NAGE?

Which has more volatility & risk, ETHZ or NAGE?

Does the media prefer ETHZ or NAGE?

Do analysts prefer ETHZ or NAGE?

Summary

How does Flag Ship Acquisition compare to Abeona Therapeutics?

Which has better valuation & earnings, ABEO or ETHZ?

Which has more risk and volatility, ABEO or ETHZ?

Do insiders and institutionals believe in ABEO or ETHZ?

Is ABEO or ETHZ more profitable?

Do analysts rate ABEO or ETHZ?

Does the media refer more to ABEO or ETHZ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ETHZ vs. The Competition

Flag Ship Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools